A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

Condition:   FSGS Interventions:   Drug: DMX-200;   Drug: Placebo Sponsor:   Dimerix Bioscience Pty Ltd Not yet recruiting

Source: ClinicalTrials.gov - January 10, 2022 Category: Research Source Type: clinical trials